CVE-2017-17678

Опубликовано: 19 мая 2021

Источник: nvd

CVSS3: 6.1

CVSS2: 4.3

EPSS Низкий

Описание

BMC Remedy Mid Tier 9.1SP3 is affected by cross-site scripting (XSS). A DOM-based cross-site scripting vulnerability was discovered in a legacy utility.

Ссылки

http://bmc.com
Product
http://remedy.com
Product
https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
Release Notes
Vendor Advisory
https://seclists.org/fulldisclosure/2017/Oct/52
Mailing List
Third Party Advisory
http://bmc.com
Product
http://remedy.com
Product
https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html
Release Notes
Vendor Advisory
https://seclists.org/fulldisclosure/2017/Oct/52
Mailing List
Third Party Advisory

Уязвимые конфигурации

Конфигурация 1

cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:*

EPSS

Процентиль: 64%

0.00465

Низкий

6.1 Medium

CVSS3

4.3 Medium

CVSS2

Дефекты

CWE-79

Связанные уязвимости

GHSA-w2cx-4cp9-hmm4

github

больше 3 лет назад